Cargando…
A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen
Human CD8(+) cytotoxic T lymphocytes can mediate tumor regression in melanoma through the specific recognition of HLA-restricted peptides. Because of the relatively weak affinity of most anti-cancer T-cell receptors (TCRs), there is growing emphasis on immunizing melanoma patients with altered pepti...
Autores principales: | Bianchi, Valentina, Bulek, Anna, Fuller, Anna, Lloyd, Angharad, Attaf, Meriem, Rizkallah, Pierre J., Dolton, Garry, Sewell, Andrew K., Cole, David K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861463/ https://www.ncbi.nlm.nih.gov/pubmed/26917722 http://dx.doi.org/10.1074/jbc.M115.707414 |
Ejemplares similares
-
TCR/pMHC Optimized Protein crystallization Screen
por: Bulek, Anna M., et al.
Publicado: (2012) -
Peptide Super-Agonist Enhances T-Cell Responses to Melanoma
por: Galloway, Sarah A. E., et al.
Publicado: (2019) -
T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions
por: Cole, David K., et al.
Publicado: (2014) -
T cell receptor alpha variable 12‐2 bias in the immunodominant response to Yellow fever virus
por: Bovay, Amandine, et al.
Publicado: (2017) -
Structural Mechanism Underpinning Cross-reactivity of a CD8(+) T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase
por: Cole, David K., et al.
Publicado: (2017)